Monocytes, macrophages, and DCs form networks of phagocytic cells throughout most tissues, the development of which are dependent on the CSF-1 receptor (csf1r, also known as CD115, c-fms, and M-CSF receptor) ( 1, 2 ) . These cells, which are sometimes referred to as the mononuclear phagocyte system, play major roles in development, scavenging, infl ammation, and antipathogen defenses ( 3, 4 ) . They are highly heterogeneous in phenotype, tissue distribution, and function ( 3, 5, 6 ) . Considerable attention is currently focused on the characterization of their progenitors and precursors, the signals driving their development in the BM, their migration to tissues, and their homeostasis in peripheral tissues. CSF-1R and its two known ligands, M-CSF and IL34 ( 7 ) , are critical for the development of this lineage because M-CSF -defi cient mice (op/ op and csf1 Ϫ / Ϫ ) have a milder phenotype than the Csf1r-defi cient mice ( 8 ) . Other cytokines, such as GM-CSF, FLT3, LT-␣ 1 ␤ 2 (LT-␣ ) ( 9 -15 ) , and chemokines ( 16, 17 ) have also been shown to control the development and homeostasis of the macrophage and DC networks.
Cellular cloning and transplantation studies have shown that many macrophage subsets, most of the conventional DCs (cDCs) in the secondary lymphoid organs of mice, and at least a fraction of the DCs in the mouse thymus probably originate from myeloid progenitors ( 18 -20 ) .
macrophage/DC lineage. The MDP is also characterized by a low expression of CD117 (c-kit, the receptor for stem cell factor), as compared with GMPs and CMPs ( 22 ) , and expression of functional CSF-1R (CD115) and FLT3 (CD135) ( 9, 22 ) . More recently, a precursor common to cDCs and PDCs (CDP) was reported and proposed to be distinct from the MDPs because the CDP gave rise to both cDCs and PDCs but not to monocytes/macrophages, whereas the MDPs give rise to cDCs and monocytes/macrophages but not to PDCs ( 24, 25 ) . We performed an analysis of mouse BM Lin Ϫ precursors by fl ow cytometry ( Fig. 1 a ) , and the results indicated that most CDPs expressed CX 3 CR1 at levels similar to its level of expression on MDPs, and that most MDPs expressed both CSF-1R/CD115 and CD135 at levels similar to their expression on CDPs ( Fig. 1 ) . These data confi rm the data from Waskow et al. ( 9 ) suggesting that MDPs and CDPs had an overlapping phenotype in the BM, and we therefore sought to reevaluate the diff erentiation potential of MDPs.
Granulocyte-macrophage progenitors (GMPs [reference 21 ]) include a clonogenic BM macrophage/DC precursor (MDP) that gives rise to spleen cDCs (both the CD11c + CD8 ␣ + CD11b Ϫ and CD11c + CD8 ␣ Ϫ CD11b + subsets) directly, with no monocytic intermediate, and to monocytes and macrophages ( 9, 22, 23 ) . The MDP has no signifi cant granulocytic potential, and initial studies failed to detect a plasmacytoid DC (PDC) potential ( 9, 22 ) . Another precursor, common DC precursor (CDP), was recently shown to give rise to cDCs and PDCs but not to monocytes, and it did not respond to CSF-1 ( 24, 25 ) . This result was interpreted as indicating the existence of two pathways for cDC generation. However, MDPs and CDPs are both included in the CD115 + lin Ϫ fraction of BM progenitors ( 9 ) and could represent diff erent stages of diff erentiation along the same pathway. It is also possible that diff erences in diff erentiation potential between these cells reported by diff erent groups may refl ect diff erences in experimental protocols rather than intrinsic properties of the cells.
The chemokine receptor and adhesion molecule CX 3 CR1 is not expressed on early hematopoietic progenitors and is fi rst detected on MDPs. CX 3 CR1 is therefore associated with the commitment of myeloid progenitors to the monocyte/macrophage/DC lineage ( 22 ) . However, its role in the development and homeostasis of cells of the mononuclear phagocyte system remains unknown.
In this paper, we therefore reevaluated the diff erentiation potential of the MDP and the possible roles of CX 3 CR1 in the diff erentiation of mononuclear phagocytes in mice using adoptive transfer and disease models. We found that MDPs can give rise to PDCs, as well as to cDCs and monocytes, after adoptive transfer and that MDPs and CDPs share a similar surface phenotype (Lin Ϫ IL7Ra Ϫ CD117 int CD135 + CD115 + CX 3 CR1 + ). The use of AFS98, an antibody designed to block CSF-1 binding to its receptor CD115, and CSF-1 -dependent proliferation ( 26 -28 ) to purify MDP did not impair the ability of MDP to give rise to monocytes, cDCs, or PDCs in vivo. Because MDP can give rise to PDCs, cDCs, and monocytes/ macrophages, whereas CDP only give rise to PDCs and cDCs ( 24, 25 ) , MDP appears to exhibit a broader diff erentiation potential than CDP and may represent an earlier precursor. CX 3 CR1 defi ciency decreased the recruitment into the spleen of CD115 + Gr1 + monocytes (TipDC precursors) after irradiation and during acute Listeria monocytogenes infection and decreased the effi ciency of bacterial clearance but did not aff ect the development of cDCs or PDCs. The results from this study, therefore, clarify the family tree of mononuclear phagocytes and uncover the role of CX 3 CR1 in Gr1 + monocyte recruitment to the spleen during infl ammation and infection.
RESULTS

MDPs and CDPs are phenotypically overlapping cell populations in mouse BM
Expression of the chemokine receptor CX 3 CR1 in GMPs (Lineage Ϫ CD117 + Sca1 Ϫ IL7R ␣ Ϫ CD34 + CD16/32 + BM cells) ( 21 ) characterizes the MDP ( 22 ) and is thus associated with the commitment of myeloid progenitors toward the ent ( Fig. 3 b ) . When both donor mice were of the Cx 3 cr1 +/ Ϫ genotype, CD45.2 and CD45.2/CD45.1 MDPs contributed equally to cDCs, PDCs, and CD11b + CD11c Ϫ monocytes ( Fig. 3, b and c ( Fig. 3, b and d ) . However, CX 3 CR1-defi cient MDP generated spleen CD11b + CD11c Ϫ cells with an effi ciency of one fi fth to one tenth that of the control ( Fig. 3, b and d ) . MDP-derived CD11b + CD11c Ϫ splenocytes were negative for NK1.1, CD3, CD19, and Ly6G and expressed high levels of CX 3 CR1 and intermediate levels of F4/80, and most of these cells expressed Gr1 ( Fig. 3 e ) . These characteristics are similar to those of CD115 + Gr1 + blood monocytes ( 29 ) and of spleen monocytes, as recently described by Nahrendorf et al. ( 32 ) . Thus, we concluded that CX 3 CR1 may be selectively involved in the development, recruitment, proliferation, and/or survival of CD11b + CD11c Ϫ monocytes in the spleen. The only known ligand of CX 3 CR1 is the transmembrane chemokine fractalkine/CX 3 CL1, which is expressed in neurons, endothelial cells, and DCs ( 33 -37 ) . CX 3 CR1 is involved in the adhesion of leukocytes, including monocytes in particular, to endothelial cells ( 38 -42 ) and in the migration of microglial cells ( 43 ) . Fractalkine is expressed in the T cell areas of lymph nodes ( 37 ) . PCR and in situ hybridization experiments indicated that CX 3 CL1 was also expressed in the spleen ( Fig. 4 , a and b ; and Fig. S4 , available at http://www.jem.org/cgi/ content/full/jem.20081385/DC1). Spleen CX 3 CL1 -producing cells were located at the periphery of the B cell follicle, effi ciency of single MDP seeded into 96-well plates in the presence of CSF-1, as well as the size of colonies, was reduced when AFS98 was added to the antibody cocktail used for cell sorting (Fig. S3 , available at http://www.jem .org/cgi/content/full/jem.20081385/DC1). However, addition of AFS98 to the antibody cocktail used for cell sorting did not aff ect the diff erentiation potential of MDP in vivo ( Fig. 2 c ) .
These data indicate that MDP and CDP share expression of CX 3 CR1, CD115, and FLT3 and have an otherwise overlapping phenotype in the BM, whereas MDP appears to have a broader diff erentiation potential than CDP after adoptive transfer in vivo because MDP gave rise to both DCs (PDCs and cDCs) and monocyte/macrophages. It is of note that addition of AFS98 to the antibody cocktail used for cell sorting decreased the proliferative response of MDP to CSF-1 in vitro but did not aff ect their diff erentiation in to DCs or monocytes in vivo.
CX 3 CR1-defi cient MDPs have a decreased potential to give rise to spleen monocytes Because expression of CX 3 CR1 is associated with the commitment of myeloid progenitors to the monocyte/macrophage/DC lineage, we investigated the role of CX 3 CR1 in the homeostasis of this lineage. The number of MDPs in the BM was not aff ected by CX 3 CR1 defi ciency ( Fig. 3 a ) defi cient BALB/c mice, the number of monocytes was increased in the blood, whereas the number of monocytes in the spleen was decreased in comparison with controls ( Fig. 4 d ) . A similar phenomenon was observed in C57BL/6 mice ( Fig. 5 , e and f ) both for high (3 × 10 5 Lm ; Fig. 4 e ) and low (7 × 10 3 Lm ; Fig. 5 f ) numbers of bacteria. To investigate whether the proliferation of blood monocytes in the spleen of Lm -infected mice was involved in their accumulation in the spleen, monocytes from the BM and spleen of infected mice at 16 and 48 h after infection were isolated by fl ow cytometry and analyzed for DNA content using propidium iodide (PI) staining ( Fig. 4 g ( Fig. 4,  a and b ). The precise identifi cation of CX 3 CL1 -expressing cells in the spleen will require the availability of specifi c antibodies; however, localization of C x 3 cl1 messenger RNA is compatible with the expression of CX 3 CL1 in the marginal zone/T cell area of the spleen and, thus, with a role of CX 3 CL1 in the recruitment of blood monocytes.
We tested the role of CX 3 CR1 for the recruitment of monocytes in the spleen by adoptive transfer of monocytes and during infection with Lm . Short-term competitive transfer of BM monocytes from donors of Cd45.2 and Cd45.2/ Cd45.1 genotype into irradiated Cd45.1 congenic recipients indicated that CX 3 CR1-defi cient monocytes were only one tenth as effi cient as control monocytes at accumulating in the spleen ( Fig. 4 c ) . During Lm infection in CX 3 CR1- 
CD115 + Gr1 + monocytes recruited to the spleen during Lm infection differentiate into effector cells (TipDCs) that produce TNF, inductible nitric oxide synthase (iNOS), and reactive oxygen intermediates (ROIs)
Because the decreased recruitment of monocytes in the spleen during Lm infection in CX 3 CR1-defi cient mice correlated with a decreased bacterial clearance, we investigated whether monocytes recruited to the spleen may be involved in the control of Lm growth and express eff ector activities important for Lm clearance such as TNF-␣ secretion, iNOS expression, and reactive oxygen production. Monocytes have already been proposed to be precursors of TipDCs that accumulate to the spleen of mice infected with Lm , produce TNF-␣ and iNOS, and are needed for the control of primary infection ( 44 -46 ) . Recruited monocytes were the majority (90%) of the CD115 + Gr1 + subset (Fig. S7 , available at http://www .jem.org/cgi/content/full/jem.20081385/DC1). In spleen, lineage Ϫ (Ly6G, NK1.1, CD3, and CD19) CD11b + CD11c Ϫ splenocytes were identifi ed as monocytes based on their expression of CD115, Ly6C/Gr1, and F4/80 ( Fig. 5 a ) ( 32 ) . We observed that these spleen CD115 + Gr1 + monocytes produced TNF-␣ , iNOS, and ROI in mice during infection after infection and, thus, that accumulation of spleen monocytes during infection is not a result of their proliferation in the spleen. In addition, the proportion of splenic monocytes that bind annexin-V in Lm -infected mice was similar in CX 3 CR1-defi cient animals and in controls (Fig. S6 ), indicating that the apoptosis rate of CX 3 CR1-defi cient Gr1 + monocytes during Lm infection was not increased in comparison with controls.
Early control of Lm growth in the spleen was also significantly less effi cient in CX 3 CR1-defi cient mice on both BALB/c and C57BL/6 backgrounds ( Fig. 4 , h and i ). Bacterial load in the spleen 24 h after an i.v. infection was 4 × higher in BALB/c Cx 3 cr1 Ϫ / Ϫ mice in comparison with controls ( Fig. 5 h ) and at least twice as high in C57BL/6 ( Fig. 4 i ) .
Altogether, these data indicate that CX 3 CR1 is important for the recruitment of monocytes to the spleen in irradiated host and during Lm infection, and for the early control of bacteria growth. It is of note that the frequency of monocytes in the spleen of noninfected mice were not aff ected by CX 3 CR1 defi ciency ( Fig. 4 d ) , indicating that CX 3 CR1 is dispensable for the recruitment of monocytes in the spleen in the steady state but important during acute infl ammation. CR1 defi cient), both donors contributed equally to CD11c + cDCs in R1 and R2 but CD45.1/2 Cx 3 cr1 +/ Ϫ MDP s were 10 × more effi cient than CD45.2/2 CX 3 CR1-defi cient MDP s in generating CD11b + CD11c Ϫ splenocytes in R3. Results in b are from one representative experiment out of three, with two to three mice per experimental group, and bar graphs in c and d represent the mean and SD from three independent experiments. The asterisk indicates a signifi cative difference between groups (P < 0.05 using the Wilcoxon test). monocytes or decreased survival, proliferation, or diff erentiation of MDP. As indicated by Fig. 4 g (Fig. S9, a -c) , and the proportion of Gr1 + blood monocytes that bind annexin-V in the steady state was also similar in CX 3 CR1-defi cient animals and in controls (Fig. S9 d) . However, there was a 20% decrease in the numbers with Lm ( Fig. 5, b -d ; and Fig. S8 ) and were localized in the T cell area and in the perifollicular area of the spleen ( Fig. 5 e ) . Altogether, these data therefore indicate that MDPs give rise to blood CD115 + Gr1 + monocytes, which are recruited to the spleen during infection via a process that involves CX 3 CR1, and that these cells expressed eff ector functions that are important for Lm elimination.
Gr1 + monocyte survival and MDP survival and proliferation are normal in CX 3 CR1-defi cient mice Other mechanisms that might be responsible for the impaired accumulation of CX 3 CR1-defi cient CD115 + Gr1 + monocytes in the spleen include decreased survival or proliferation of cDCs and monocytes were no longer labeled (Fig. S10 d) , indicating they that had undergone multiple rounds of division. Together with results from the adoptive transfer experiments depicted in Fig. 4 , these data indicate that CX 3 CR1 defi ciency does not signifi cantly aff ect the proliferation and diff erentiation potential of MDP.
DISCUSSION
This study investigated the diff erentiation potential of the CX 3 CR1 + MDPs and the role of CX 3 CR1 in their development. First, our data confi rmed that CX 3 CR1 was associated with the commitment of myeloid progenitors to the monocyte/macrophage/DC lineage. The recently described CDP ( 24, 25 ) also expresses CX 3 CR1, CD115, and FLT3, and its phenotype was overlapping with the MDP (this study and of blood Gr1 Ϫ monocytes in CX 3 CR1-defi cient and CX 3 CL1-defi cient mice in comparison with controls (Fig. S9, a -c) , and the frequency of apoptotic Gr1 Ϫ monocytes was higher in Cx 3 cl1 Ϫ / Ϫ mice in comparison with WT mice (Fig. S9 d) .
The clonogenic and proliferation potentials of MDPs were then studied in vitro in the presence or absence of CX 3 CL1/ fractalkine. CX 3 CR1/CX 3 CL1 did not confer any advantage in terms of growth or survival, even in competition with WT cells (Fig. S10, a - the endothelium for considerable periods of time without extravasation ( 42 ) . Human CX 3 CR1 high cells also adhere to the endothelium via a CX 3 CR1-dependent mechanism ( 38 ) , and adhesion is known to increase survival as has been shown for CX 3 CR1-expressing cells binding to CX 3 CL1 via a mechanism involving an Akt/GSK-3 ␤ -mediated antiapoptotic signaling pathway ( 48, 49 ) .
The role of CX 3 CR1 for the recruitment of CD115 + Gr1 + monocytes/TipDC precursors is reminiscent of the phenotype of CCR2-, MCP1-, and MCP3-defi cient mice ( 45, 50 ) . However, the disruption of the CCR2 axis results in a much more dramatic phenotype because both Gr1 + monocytes exit from the BM into the bloodstream, and the recruitment into tissues of the few monocytes that exit the BM is impaired in these mice ( 45, 46, 50 ) . Thus CCR2-defi cient mice have reduced numbers of TipDCs. In contrast, BM output is intact in CX 3 CR1-defi cient mice, the number of blood Gr1 + monocytes are normal, and only their recruitment is impaired. Similarly, CCR2-defi cient mice have a dramatically impaired innate response to Lm infection and die of infection within a few days ( 46 ) , whereas CX 3 CR1-defi cient hosts exhibit a reduced clearance of Lm at 24 h after infections ( Fig. 3 ), but at later time points we did not observe signifi cant diff erences in the survival of CX 3 CR1-defi cient and control mice (not depicted). We therefore propose that CX 3 CR1 may play an important role in mediating the recruitment of CD115 + Gr1 + infl ammatory monocytes in the white pulp of the spleen during acute infl ammation, possibly through adhesion to the capillary endothelial cells of the marginal zone of the spleen.
MATERIALS AND METHOD S
Animals. C57BL/6 mice on Cd45. 2 cl1 Ϫ / Ϫ mice were maintained in the laboratory of I.F. Charo (Gladstone Institute of Cardiovascular Disease, University of California, San Francisco, San Francisco, CA). All mice were maintained according to institutional guidelines and used at the age of 8 -14 wk old. 4-wkold C57BL/6 mice on the Cd45.1 background were used as adoptive transfer recipients. Experimental protocols using mice were examined and approved by the Direction Departementale des Services V é t é rinaires de Paris (Paris, France).
Antibodies and recombinant proteins. The following purifi ed or conjugated antibodies were purchased from BD: purifi ed anti-Fc ␥ RIII/II (CD32/16, clone 2.4G2); PE-, APC-, PcP-, or biotin-labeled anti-CD11b (M1/70); PE-, APC-, or biotin-labeled anti-CD117 (cKit; 2B8); PE-or APC-labeled anti-NK1.1 (PK136); FITC-, PE-, or APC-labeled anti-CD11c (HL3); PE-or APC-labeled anti -TCR-␤ (H57-597); PE-or APC-labeled anti-B220 (RA3-6B2); biotin-labeled anti-CD45.2 (104); FITC-or biotinlabeled anti-Ly6C (AL-21); PE-labeled anti-Ly6G (1A8); PE-Cy7 -labeled anti -CD8-␣ (53 -6.7); PerCP-labeled anti-CD4 (RM4-5); PE-labeled anti-CD3 (145-2C11); PE-labeled anti-CD19 (MB19-1); APC-labeled anti -TNF-␣ (MP6-XT22); and control rat IgG 1 mAb. The following antibodies were purchased from eBioscience: PE-Cy7 -labeled anti-CD45.1 (A20), reference 9 ). MDP can give rise to both DCs (PDCs and cDCs) and monocytes/macrophages but do not have the potential to give rise to granulocytes. Thus, they have a more restricted diff erentiation potential than CMPs, which can give rise to all myeloid cells, and GMPs, which can give rise to granulocytes, macrophages, and DCs ( Fig. 2 d ) . CDP has been reported to give rise to cDCs and PDCs but not macrophages and, thus, has a more restricted diff erentiation potential than MDPs and may be placed downstream ( Fig. 2 d ) . Further studies will be needed to investigate the developmental relationship between MDPs and CDPs.
CX 3 CR1 is a later marker than CSF-1R in myeloid lineage commitment. In this study, we investigated the role of CX 3 CR1/CX 3 CL1 in the development of MDP-derived cells by studying mice lacking CX 3 CR1 or its ligand CX 3 CL1/fractalkine during acute and chronic infl ammation and in a sensitive competitive adoptive transfer model. This study revealed an important role of CX 3 CR1 in the recruitment of CD115 + Gr1 + infl ammatory monocytes, which are immediate precursors to TipDCs, to the spleen during infection and for the control of bacterial growth during primary infection in two diff erent strains of mice (C57BL/6 and BALB/c).
Impaired recruitment of CX 3 CR1-defi cient Gr1 + monocytes/TipDCs is the most likely mechanism underlying our observations for the following reasons: in situ hybridization experiments ( Fig. 4 and Fig. S4 ) indicated that fractalkine is expressed in the marginal zone/T cell areas of the spleen, where TipDC accumulate during infection ( Fig. 5 ) ( 44 ) ; short-term adoptive transfer of BM monocytes into irradiated hosts decreased the accumulation of CX 3 CR1-defi cient monocytes in the spleen by a factor of ten (see Fig. 4 ) ; during acute Lm infection, the number of monocytes was higher in the blood of infected CX 3 CR1-defi cient mice but decreased in the spleen ( Fig. 4 ) , and the frequency of annexin-V high monocytes was not increased in spleen from infected CX 3 CR1-defi cient mice (Fig. S6) ; CX 3 CR1 defi ciency does not appear to infl uence the survival of CD115 + Gr1 + monocytes in the periphery (Fig. S9) ; and fi nally, we have found that CX 3 CR1 was redundant for MDP development, survival, homing to the spleen, and diff erentiation in vivo and in vitro (Fig. S10) and MDP-derived spleen cDCs and PDCs appear to develop normally.
It is of note that although CD115 + Gr1 + (CX 3 CR1 low ) infl ammatory monocytes were present in normal numbers in both CX 3 CR1-and CX 3 CL1-defi cient mice, the present data confi rm that CX 3 CR1 defi ciency also slightly decreases the survival of the CD115 + Gr1 Ϫ monocytes (Fig. S9) . This result was expected and consistent with the conclusions that we made from our earlier adoptive transfer experiments ( 29 ) and with a more recent study ( 47 ) . CX 3 CR1 has been previously shown to be important for the adhesion of CD115 + Gr1 Ϫ (CX 3 CR1 high ) monocytes to the endothelium of blood vessels ( 38, 42 ) . The mechanism underlying the selective survival defect of CD115 + Gr1 Ϫ CX 3 CR1 high monocytes may thus be related to the unique patrolling behavior of these cells, which attach themselves to the luminal side of the endothelium via a CX 3 CR1-and LFA1-dependent mechanism, crawling onto with collagenase d , homogenized, and fi ltered. Erythrocytes were lysed using red blood cell lysis buff er for quantifi cation of cell populations in reporter mice or were depleted by density gradient centrifugation (LSM 1077; Eurobio) for analysis of adoptive transfer recipients. PBMC or splenic mononuclear cell suspensions were enumerated with a Guava Viacount analyser. Fc receptors were blocked, and then cells were labeled using fl uorochromeor biotin-conjugated antibodies and analyzed by fi ve, six, or seven-color fl ow cytometry using a Cyan ADP.
For in vivo proliferation assays, splenocytes or FACS-sorted MDP were labeled using BODIPY far-red cell tracker (Invitrogen), transferred to congenic recipients, and analyzed by fl ow cytometry after 5 d. Cell division of MDP-derived cells was assessed by comparison with nondividing B220 + B lymphocytes.
In vitro analysis of cell survival, proliferation, and diff erentiation potential. MDPs from C x 3 cr1 +/ Ϫ or C x 3 cr1 Ϫ / Ϫ were purifi ed by FACS, as described in the previous section, and plated at one cell per well into 96-well plates containing Opti-MEM (Invitrogen) supplemented with 10% FCS (PAN biotech), 100 U/ml penicillin, and 100 μ g/ml streptomycin (Invitrogen) along with CSF-1, GM-CSF, or both (10 ng/ml each unless otherwise indicated) in the presence or absence of recombinant CX 3 CL1. Resulting colonies were enumerated after incubation at 37 ° C in 5% CO 2 for 7 d. For diff erentiation analysis, colonies were recovered from wells by vigorous pipetting and were immunolabeled for cell surface markers as described in the previous section. For determination of proliferation potential, individual cells from colonies arising from single cell clones were counted using a 10 or 5 × objective on a microscope (Axiovert; Carl Zeiss, Inc.). Counting accuracy was validated by digital analysis of random colonies of various sizes photographed using a camera (CoolSnap ES; Roper Scientifi c) and Photoshop CS (Adobe) for marking of individual cell bodies.
For analysis of proliferation under competitive conditions, 100 MDPs each from C x 3 cr1 +/ Ϫ and Cx 3 cr1 Ϫ / Ϫ mice on diff erent CD45 congenic backgrounds, as described in the Animals section, were deposited into wells of 96-well roundbottom plates, coated with fractalkine or BSA as control, and grown in decreasing concentrations of CSF-1. After 5 d in culture, cells were harvested from individual wells and analyzed for origin by CD45.1 and CD45.2 staining by fl ow cytometry. At least 10 wells were analyzed per experiment.
Lm infection. The Lm 10403s WT strain was used in these experiments. This strain exhibit an LD 50 of 7 × 10 4 in C57BL/6 mice. Bacteria were prepared from clones grown from organs of infected mice. Stocks of bacteria were kept frozen at Ϫ 80 ° C. For infections, bacteria were grown to a logarithmic phase (OD 600 = 0.05 -0.15) in Broth Heart Infusion medium (Sigma-Aldrich), diluted in PBS, and injected i.v. into lateral tail vein with 0.1 -10 × LD 50 of WT Lm per mouse. To study production of TNF and iNOS, organs were cut in small pieces and incubated at 37 ° C for 20 min in HBSS medium (Invitrogen) containing 4,000 U/ml collagenase I (Invitrogen) and 0.1 mg/ml DNase I (Roche). Red blood cells were lysed for 2 -3 min in 170 mM NH 4 Cl and 17 mM Tris HCl, pH 7.4. Cells were stained with the specifi ed antibodies in 100 ml PBS containing 0.5% of BSA (FACS buff er). For the TNF-␣ intracellular staining, splenocytes were incubated at 37 ° C and 5% CO 2 for 3 -4 h in RPMI 1640 (Invitrogen) containing 5% FCS and 2 mg/ml Golgi Plug (BD) with or without 5 × 10 8 HKLM/ml. Cells were incubated for 20 min on ice with the indicated cell surface marker mAbs, fi xed in 1% PFA FACS buff er for 20 min on ice, and permeabilized for 30 min in Perm/Wash (BD). For intracellular staining of TNF-␣ , cells were incubated for 20 min on ice in FACS buff er containing anti -TNF-␣ or control rat IgG 1 . For intracellular staining of iNOS, cells were incubated for 20 min on ice in FACS buff er containing antiiNOS rabbit polyclonal or control normal goat IgG, and staining was revealed using goat anti -rabbit Alexa Fluor 647 mAb. In all cases, cells were washed, fi xed for 30 min in 1% PFA FACS buff er, and analyzed on a FACSCalibur cytofl uorometer (BD). To study the production of ROI, 5 -10 × 10 6 splenocytes were incubated for 3 h at 37 ° C and 5% CO2 in 5% FCS RPMI 1640 with 5 × 10 8 HKLM/ml and 160 μ M hydroethidine. Hydroethidine is oxidized by ROI in red fl uorescent ethidium bromure, therefore allowing for the detection APC -Alexa Fluor 750-labeled anti-CD45.2 (104), PE-or PE-Cy5 -labeled anti-Flt3 (A2F10), and PE-or biotin-labeled anti CD115 (AFS98). Anti-CD169 (MOMA-1) and APC-or biotin-labeled F4/80 clone Cl:A3-1 were purchased from AbD Serotec. mPDCA1 antibody was purchased from Miltenyi Biotec. Anti -NOS-2 (M-19) polyclonal rabbit was purchased from Santa Cruz Biotechnology, Inc. Goat anti -rabbit Alexa Fluor 647 was purchased from Invitrogen. Hydroethidine was purchased from Polysciences, Inc. Antibodies used for depletion, including TER-119 (erythrocytes), RB6-8C5 (Ly6-C/G), and GK1.5 (CD4), were supernatants of hybridomas donated by B. Rocha (IFR Necker, Paris, France). Streptavidin Pacifi c Blue was purchased from Invitrogen. Dead cells were gated out by PI labeling (Invitrogen). APC-labeled annexin V was purchased from BD. Recombinant mouse macrophage CSF-1 and recombinant mouse fractalkine (CX 3 CL1) were purchased from R & D Systems. Recombinant mouse GM-CSF was purchased from PeproTech.
Mouse blood phenotyping. Blood was drawn according to institutional guidelines, and red blood cells were lysed in 5 vol of red blood cell lysis buffer (155 mM NH 4 Cl, 10 mM NaHCO 3 , and 0.1 mM EDTA). Cell suspensions were fi ltered using a 40-μ m fi lter (BD), washed twice in PBS 0.5% BSA, and an aliquot was counted with a Guava ViaCount analyzer (Guava Technologies). Cells were incubated with anti -mouse FcRII/III (2.4G2) for 10 min at 4 ° C in PBS 0.5% BSA and then stained with anti -mouse antibodies specifi c for CD11b (PE-Cy7), Ly6C (biotin), NK1.1 (APC), and CD115 (PE). Biotinylated antibodies were revealed by subsequent staining with streptavidin -Pacifi c blue. Cells were analyzed on a nine-color CYAN ADP fl ow cytometer (Dako) using the Summit 4.3 software (Dako), and monocytes were identifi ed as CD115 + , CD11b + , SSC lo , NK1.1 Ϫ , or Ly6c +or Ϫ cells. Annexin V staining was performed according to the manufacturer ' s instructions. Absolute numbers were calculated using cell percentages and total white blood cells counts. Data on blood monocytes counts were obtained from littermate mice at the age of 7 -8 wk for Cx 3 cr1 +/+ , Cx 3 cr1 gfp/+ , and Cx 3 cr1 gfp/gfp mice and 13 -14 wk old mice for Cx 3 cl1 +/+ and Cx 3 cl1 Ϫ / Ϫ mice.
Phenotyping of splenocytes. Spleens were removed, triturated in RPMI 2% FCS at 4 ° C with the end of a 3-ml syringe, and then passed through a 100-μ m cell strainer (BD) in one well of a 6-well plate. Cell suspensions were fi ltered using a 40-μ m fi lter, washed twice in PBS 0.5% BSA, blocked with anti -mouse FcRII/III, and then stained with anti -mouse antibodies specifi c for CD3e, CD11c, CD19, Ly6G, CD11b, Ly6C, mPDCA1, NK1.1, and CD115. Biotinylated antibodies were revealed by subsequent staining with streptavidin -Pacifi c blue. Annexin V staining was performed according to the manufacturer ' s instructions. Cells were analyzed on a CYAN ADP fl ow cytometer using Summit 4.3 software (Dako).
Phenotyping, isolation, and adoptive transfer of MDP and CDP. BM cells from femurs and tibias of Cx 3 cr1 gfp/+ mice aged 6 wk were fl ushed with serum-free RPMI, Fc receptors were blocked with antibody to Fc ␥ RIII/II (2.4G2), and cells were labeled using antibodies against lineage markers (IL7-R ␣ , CD11c, CD11b, NK1.1, CD3, Ter119, CD19, and Gr1), CD117, CD115, and CD135. For purifi cation of MDP, red blood cells and Gr1-expressing cells were removed using Ter119 and RB68C5 antibodies as previously described ( 22 ) . MDP (defi ned as IL7-R ␣ Ϫ lineage Ϫ gfp + [CX 3 CR1] CD117 int expressing CD115; Fig. S2 ), CDP (defi ned as IL7R ␣ Ϫ lineage Ϫ CD135 + CD115 + CD117 int ; Fig. S3 ), and BM monocytes (defi ned as gfp + CD11b + CD115 + NK1.1 Ϫ CD117 Ϫ ) were purifi ed by fl ow cytometry using FACSVantage or FACSAria cell sorters (BD). For competitive adoptive transfers, monocytes or MDP were purifi ed from Cx 3 cr1 gfp/gfp mice on a Cd45.2 background and from Cx 3 cr1 gfp/+ mice on a Cd45.2/.1 background, unless otherwise indicated. FACS-purifi ed cells from each genetic background were mixed at a 1:1 ratio and were transferred i.v. to 4-wk-old recipient mice on a Cd45.1 background. Recipients were either irradiated with 10 Gy or were not irradiated. For analysis of cell populations in WT mice, Cx 3 cr1 gfp reporter mice, and adoptive transfer recipients, blood and organs were harvested from anaesthetized mice as described previously ( 29 ), and spleens were digested graphic emulsion (NTB2; Eastman Kodak) for 2 mo at 4 ° C. Sections were developed, counterstained with toluidine blue (0.2% in 0.2 M sodium acetate, pH 4.3), covered with a coverslip, and examined under bright-or darkfi eld illumination with a light microscope (DNRB2; Leica). Both bright-and dark-fi eld images were collected by a charge-coupled device camera (Nikon) connected to a computer.
Online supplemental material. Fig. S1 shows the expression of CX 3 CR1 by PDCs. Fig. S2 shows the sorting gates for MDPs. Fig. S3 shows the eff ects of the AFS98 anti-CD115 antibody on the response of MDP to M-CSF in vitro. Fig. S4 shows the expression of CX 3 CL1 in the spleen. Fig. S5 shows analysis of the proliferation of monocytes in the spleen and BM. Figs. S6 and S7 show the ratio of Gr1 + and Gr1 Ϫ monocytes in the spleens of infected and control mice and the frequency of annexin-V -positive cells. Fig. S8 describes the analysis of the production of TNF, NOS2, and ROI by Gr1 + monocytes in the spleen of infected and controls mice. Fig. S9 indicates the absolute numbers of Gr1 + and Gr1 Ϫ monocytes in the blood of mice defi cient in CX 3 CR1 or CX 3 CL1 in comparison to controls. The authors have no confl icting fi nancial interests.
Immunofl uorescence. Spleens were fi xed for 1 h in medium containing 0.05 M phosphate buff er, 0.1 M l -lysine, pH 7.4, 2 mg/ml NaIO 4 , and 40 mg/ml paraformaldehyde and then dehydrated overnight at 4 ° C in a solution of 30% sucrose under agitation. Tissues were snap frozen in Tissue-Tek (Sakura). 10-μ m frozen sections were stained with Alexa Fluor 488 anti-B220 antibody (RA36B2; BD), Alexa Fluor 647 anti-CD3 antibody (17A2; BD), and unconjugated anti-NOS2 antibody (M19; Santa Cruz Biotechnology, Inc.). NOS2 staining was revealed with an Alexa Fluor 647 goat anti -rabbit IgG (Invitrogen). Immunofl uorescent confocal microscopy was performed with a laserscanning confocal microscope (TCS SP5; Leica). Final image processing was performed using ImageJ software (National Institutes of Health).
RT PCR. Standard methods were used for the preparation of total cellular RNA and fi rst-strand complementary DNA from spleens and brains of WT C57BL/6 mice. The following primer pairs were used: Cx 3 cl1 forward, 5 Ј -CATGTGCGACAAGATGACCTCA-3 Ј , and reverse, 5 Ј -TTCCAATG-C TCTGAGGCTTAGC-3 Ј (455-bp product); and cyclophilin forward, 5 Ј -TGGTCAACCCCACCGTGTTCTTCG-3 Ј , and reverse, 5 Ј -TCCAG-CATTTGCCATGGACAAGA-3 Ј (455-bp product).
In situ hybridization. The 60-mer oligonucleotide probes were synthesized and purifi ed by Invitrogen. The oligonucleotides were 3 Ј end labeled with [ 35 S]dATP (PerkinElmer) using 15 U/ml of terminal deoxyribonucleotidyl transferase (Invitrogen) to a specifi c activity of ‫ف‬ 7 × 10 8 cpm/mg. The probes were purifi ed on BioSpin columns (Bio-Rad Laboratories) before use. The Cx 3 cl1 probes were chosen according to the human Cx 3 cl1 complementary DNA sequence (available under GenBank accession no. NM_ 009142 ; http://www.ncbi.nlm.nih.gov/Genbank). The sequences of the probes were 5 Ј -CCGGAGGCCACCCTAGACCACTATTCACTTAT-CAGAGACAGAGCAGGTGACCTTCCAGCT-3 Ј for the Cx 3 cl1 sense probe (position 1443 -1503) and 5 Ј -AGCTGGAAGGTCACCTGCTCT-GTCTCTGATAAGTGAATAGTGGTCTAGGGTGGCCTCCGG-3 Ј for the Cx 3 cl1 antisense probe (position 1503 -1443). The hybridization cocktail contained 50% formamide, 4 × SSC, Denhardt ' s solution, 0.25 mg/ml of yeast transfer RNA, 0.25 mg/ml of sheared herring sperm DNA, 0.25 mg/ml poly A + , 10% dextran sulfate (SigmaAldrich), 100 mmol DTT, and [ 35 S]dATP-labeled probes (10 6 cpm/100 μ l fi nal concentration). 100 μ l of hybridization solution was applied to each section. Sections were covered with a parafi lm coverslip and incubated in a humidifi ed chamber at 43 ° C for 20 h. After hybridization, the slides were washed twice for 15 min in SSC supplemented with 10 mM DTT at 55 ° C, twice for 15 min in 0.5 × SSC supplemented with 10 mM DTT at 55 ° C, and, fi nally, in 0.5 × SSC supplemented with 10 mM DTT for 15 min at room temperature. The sections were dipped in water, dehydrated by incubation in a series of graded concentrations of ethanol, placed against x-ray fi lm (Hyperfi lm Betamax; GE Healthcare) for 10 d, and then against photo-
